Inventor
Nikki DELLAS
Inventor
US
Overview
Patents· 36 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes29%
C12YEnzymes27%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture14%
A61KPreparations for medical, dental or toiletry purposes9%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations6%
Y02EReduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution5%
C07KPeptides3%
C07HSugars2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for1%
PatentTitleYear
12,497,605Engineered acid alpha-glucosidase variants202512,454,682Engineered glycosyltransferases and steviol glycoside glucosylation methods202512,421,509Engineered phosphopentomutase variant enzymes202512,404,499Engineered glycosyltransferases and steviol glycoside glucosylation methods202512,344,865Biocatalysts and methods for hydroxylation of chemical compounds202512,344,872Engineered ligase variants202512,331,325Engineered transaminase polypeptides202512,297,462Engineered transaminase polypeptides for industrial biocatalysis202512,291,728Engineered glycosyltransferases and steviol glycoside glucosylation methods202512,286,655Human alpha-galactosidase variants202512,286,653Carboxyesterase polypeptides for amide coupling202512,252,723Ketoreductase polypeptides and polynucleotides202512,241,100Engineered leucine decarboxylases202512,110,493Engineered purine nucleoside phosphorylase variant enzymes202412,084,697Penicillin-G acylases202412,071,642Engineered amylase variants202412,018,295Engineered DNA polymerase variants202411,987,823Engineered lipase variants202411,970,722Engineered acid alpha-glucosidase variants202411,965,192Penicillin-G acylases202411,959,108Engineered protease variants202411,920,167Engineered glycosyltransferases and steviol glycoside glucosylation methods202411,795,445Engineered phosphopentomutase variant enzymes202311,788,071Engineered transaminase polypeptides202311,767,519Engineered amylase variants202311,760,981Engineered glycosyltransferases and steviol glycoside glucosylation methods202311,746,369Ketoreductase polypeptides and polynucleotides202311,591,588Penicillin-G acylases202311,473,077Engineered tyrosine ammonia lyase202211,427,813Human alpha-galactosidase variants202211,421,253Engineered tyrosine ammonia lyase202211,359,183Engineered transaminase polypeptides for industrial biocatalysis202211,299,723Engineered beta-glucosidases and glucosylation methods202211,214,786Penicillin-G acylases202211,198,861Engineered phenylalanine ammonia lyase polypeptides202111,162,105Engineered purine nucleoside phosphorylase variant enzymes2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to CODEXIS INC (28)· patent assignee history
2021–2025Based in US· patent location history
2023–2024Patents assigned to NESTLE SA (4)· patent assignee history
2024–2025Patents assigned to TATE & LYLE SOLUTIONS USA LLC (4)· patent assignee history
2025Patents assigned to CROSSWALK THERAPEUTICS INC (2)· patent assignee history
2025Patents assigned to SYNTIS BIO INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CODEXIS INC | 28 | 2021–2025 |
| NESTLE SA | 4 | 2023–2024 |
| TATE & LYLE SOLUTIONS USA LLC | 4 | 2024–2025 |
| CROSSWALK THERAPEUTICS INC | 2 | 2025 |
| SYNTIS BIO INC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 36 | 2021–2025 |